×
About 31,118 results

ALLMedicine™ Psoriasis Center

Research & Reviews  8,973 results

Psoriasis Susceptibility 1 Candidate 1 (PSORS1C1) Polymorphism is Associated with Autoi...
https://doi.org/10.1080/08820139.2021.1923734
Immunological Investigations; Jiang Y, Mao X et. al.

Jul 31st, 2021 - Autoimmune thyroid disease (AITD) is an inherited, complex gene- and immune-related disorder that mainly includes Graves' disease (GD) and Hashimoto's thyroiditis (HT). Psoriasis susceptibility 1 candidate 1 (PSORS1C1) is a susceptibility gene ass...

Del-1 in psoriasis induced the expression of αvβ3 and α5β1 in endothelial cells.
https://doi.org/10.2174/1566524021666210729112700
Current Molecular Medicine; Niu X, Han Q et. al.

Jul 31st, 2021 - Psoriasis is a chronic inflammatory skin disease highly depending on angiogenesis. Our prior results showed that the mRNA and protein of Del-1 in dermal mesenchymal stem cells (dMSCs) was up-regulated from psoriasis. Our aim was further to investi...

Successful treatment of tinea capitis caused by Microsporum canis in a 23-day-old newbo...
https://doi.org/10.1111/dth.15078
Dermatologic Therapy; Zhou YB, Xiao YY et. al.

Jul 31st, 2021 - Although tinea capitis is common in children, but it is rare in newborns. It should be differentiated with neonatal lupus erythematosus, nummular eczema, psoriasis, seborrheic dermatitis, erythema annular centrifugum, annular urticaria, and annula...

Oral simvastatin combined with narrowband UVB for the treatment of psoriasis: a randomi...
https://doi.org/10.1111/dth.15075
Dermatologic Therapy; Al Salman M, Ghiasi M et. al.

Jul 31st, 2021 - Psoriasis is a common chronic skin condition, which is an immune-related hyperproliferative disorder. Among the different treatments for psoriasis, statins have been found to reduce the severity of the disease. Accordingly, fluvastatin and simvast...

Biologicals for moderate-to-severe plaque type psoriasis in pediatric patients.
https://doi.org/10.1080/1744666X.2021.1958675
Expert Review of Clinical Immunology; Libon F, Lebas E et. al.

Jul 31st, 2021 - Psoriasis affects around 2% of children in Europe. The majority of cases is readily managed with topical treatments using corticosteroids without or with calcipotriol. More resistant and extensive moderate-to-severe cases require UVA or UVB photot...

see more →

Guidelines  22 results

EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris - Part 2: specifi...
https://doi.org/10.1111/jdv.16926
Journal of the European Academy of Dermatology and Venere... Nast A, Smith C et. al.

Feb 7th, 2021 - This evidence- and consensus-based guideline on the treatment of psoriasis vulgaris was developed following the EuroGuiDerm Guideline and Consensus Statement Development Manual. The second part of the guideline provides guidance for specific clini...

Topical Treatment of Psoriasis Vulgaris: The Swiss Treatment Pathway.
https://doi.org/10.1159/000512930
Dermatology (Basel, Switzerland); Maul JT, Anzengruber F et. al.

Jan 7th, 2021 - Topical treatment is crucial for the successful management of plaque psoriasis. Topicals are used either as a stand-alone therapy for mild psoriasis or else in combination with UV or systemic treatment for moderate-to-severe disease. For the choic...

Portuguese recommendations for the treatment of psoriasis with biologic therapy.
https://doi.org/10.1684/ejd.2020.3945
European Journal of Dermatology : EJD; Torres T, Tavares Bello R et. al.

Dec 11th, 2020 - Psoriasis is a highly prevalent chronic, inflammatory multisystem disease with a considerable impact on patients' quality of life and the healthcare system. This report presents the recommendations developed by the Portuguese Psoriasis Group of th...

Updates on treatment guidelines for psoriasis, atopic dermatitis (eczema), hidradenitis...
https://www.ncbi.nlm.nih.gov/pubmed/33147660
Dermatology Online Journal; Yim RM, Singh I et. al.

Nov 5th, 2020 - Owing to the evolving COVID-19 pandemic and emerging data regarding immunosuppressant therapies for inflammatory cutaneous diseases, dermatologists are being encouraged to reevaluate their patients' treatment regimens to minimize any potential ris...

National Psoriasis Foundation COVID-19 Task Force Guidance for Management of Psoriatic ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471802
Journal of the American Academy of Dermatology; Gelfand JM, Armstrong AW et. al.

Sep 7th, 2020 - To provide guidance about management of psoriatic disease during the coronavirus disease 2019 (COVID-19) pandemic. A task force (TF) of 18 physician voting members with expertise in dermatology, rheumatology, epidemiology, infectious diseases, and...

see more →

Drugs  829 results see all →

Clinicaltrials.gov  619 results

Psoriasis Microbiome and Phototherapy
https://clinicaltrials.gov/ct2/show/NCT02552316

May 8th, 2020 - The ASPIRE study is a clinical trial designed to examine the microbes (e.g., bacteria) within psoriasis skin lesions compared with normal skin. The investigators will also examine the effect of NB-UVB (narrow-band ultraviolet B) phototherapy (i.e....

Apremilast Safety and PK Study in Recalcitrant Plaque Psoriasis
https://clinicaltrials.gov/ct2/show/NCT00521339

May 7th, 2020 - This is a phase 2, multicenter, open-label, study to evaluate the safety, tolerability, pharmacodynamics, pharmacokinetics and efficacy of Apremilast in participants with recalcitrant plaque-type psoriasis. Approximately 31 participants were enrol...

A Study of Safety, Tolerability and Pharmacokinetics of Apremilast (CC-10004) in Pediatric Subjects With Moderate to Severe Plaque Psoriasis
https://clinicaltrials.gov/ct2/show/NCT02576678

May 7th, 2020 - Each subject will undergo a screening period of up to 5 weeks, a treatment period of 2 weeks with PK sample collection, and an extension treatment period of 48 weeks, to allow subjects access to apremilast treatment if medically appropriate (follo...

Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis (PsA)
https://clinicaltrials.gov/ct2/show/NCT01307423

May 6th, 2020 - Psoriatic arthritis (PsA) is an inflammatory arthritis that occurs in 6-39% of psoriasis patients. The immunopathogenesis of PsA, which mirrors but is not identical to that seen in psoriatic plaques, reflects a complex interaction among resident d...

Serum, Cellular and Imaging Markers of Arthritis in Psoriasis Patients
https://clinicaltrials.gov/ct2/show/NCT02413801

May 5th, 2020 - Our long-term goals are to: 1) develop arthritis biomarkers in psoriasis patients that will facilitate early treatment interventions; and, 2) identify new therapeutic targets in PsA through better understanding of the underlying molecular pathogen...

see more →

News  1,971 results

COVID-19 Vaccine Hesitancy Still Weighs Heavy for Some Rheumatic Disease Patients
https://www.medscape.com/viewarticle/955156

Jul 21st, 2021 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's Coronavirus Resource Center. With 49% of the U.S. population fully vaccinated against SARS-CoV-2, a new study highlights the degree of vaccine hesitancy among patients with rh...

Fast Five Quiz: Can You Identify Psoriatic Arthritis and Initiate the Best Treatment Practices?
https://www.medscape.com/viewarticle/835807

Jul 14th, 2021 - Psoriasis is a systemic inflammatory disease that is frequently accompanied by comorbidities, including metabolic syndrome, cardiovascular diseases, and depression. Psoriatic arthritis (PsA) is a chronic inflammatory arthritis that develops in pat...

Patients on Methotrexate Show T-Cell Response to Pfizer Vaccine
https://www.medscape.com/viewarticle/954631

Jul 12th, 2021 - People taking methotrexate had low antibody responses after the first dose of the Pfizer–BioNTech mRNA COVID-19 vaccine, but did show evidence of T-cell-mediated immune responses, findings from a small study show. The common immunosuppressant has ...

Fast Five Quiz: Plaque Psoriasis Presentation and Diagnosis
https://www.medscape.com/viewarticle/929579

Jul 9th, 2021 - Psoriasis is a chronic, immune-mediated inflammatory skin disease. Globally, approximately 125 million people have psoriasis, which manifests in several ways (ie, plaque, flexural, guttate, pustular, or erythrodermic psoriasis). Plaque psoriasis i...

Fast Five Quiz: Plaque Psoriasis Management
https://www.medscape.com/viewarticle/923304

Jul 9th, 2021 - Plaque psoriasis is the most common form of psoriasis, a chronic inflammatory skin disorder that affects approximately 125 million individuals worldwide. It exerts a considerable burden on affected patients, including decreased quality of life and...

see more →

Patient Education  33 results see all →